XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]      
REVENUES, NET $ 154,541,077 $ 148,811,976 $ 164,392,555
COST OF GOODS SOLD 123,432,529 114,531,512 127,873,515
GROSS PROFIT 31,108,548 34,280,464 36,519,040
SELLING EXPENSES 27,385,587 29,177,163 30,876,959
GENERAL AND ADMINISTRATIVE EXPENSES 7,257,524 15,668,684 8,187,176
STOCK BASED COMPENSATION 10,360,000
IMPAIRMENT OF LONG-LIVED ASSETS 148,795
TOTAL OPERATING EXPENSES 34,643,111 55,205,847 39,212,930
LOSS FROM OPERATIONS (3,534,563) (20,925,383) (2,693,890)
OTHER INCOME (EXPENSES):      
INTEREST INCOME 516,637 883,908 401,921
INTEREST EXPENSE (13,604) (65,854) (262,218)
INVESTMENT LOSS (1,607,537) (2,316,994)
OTHER INCOME (EXPENSES) 467,687 1,680,087 455,547
LOSS BEFORE INCOME TAXES (4,171,380) (20,744,236) (2,098,640)
PROVISION FOR INCOME TAXES 62,862 394,541 1,099,726
NET LOSS (4,234,242) (21,138,777) (3,198,366)
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST (14) (252) (6,247)
NET LOSS ATTRIBUTABLE TO CHINA JO-JO DRUGSTORES, INC. (4,234,228) (21,138,525) (3,192,119)
OTHER COMPREHENSIVE LOSS      
FOREIGN CURRENCY TRANSLATION ADJUSTMENTS (729,373) (2,617,857) 1,534,807
COMPREHENSIVE LOSS $ (4,963,615) $ (23,756,634) $ (1,663,559)
WEIGHTED AVERAGE NUMBER OF SHARES:      
Basic (in Shares) 1,444,263 509,828 173,966
Diluted (in Shares) 1,444,263 509,828 173,966
LOSS PER SHARE:      
Basic (in Dollars per share) $ (2.93) $ (41.46) $ (18.35)
Diluted (in Dollars per share) $ (2.93) $ (41.46) $ (18.35)